CPRD (Clinical Practice Research Datalink) is the leading provider of integrated real-world research services based on longitudinal representative UK population EHR data. We provide anonymised data to academic, industry and government institutions worldwide to support public health observational research in addition to supporting recruitment of patients to clinical studies, bespoke data collection and full pragmatic trial management.
CPRD is a UK government initiative sponsored by the Medicines and Healthcare products Regulatory Agency and the National Institute for Health Research, to drive real world evidence in public health research.
CPRD provides an integrated service from discovery to post-marketing evaluation which can maximise study endpoints, data quality and generalisability. We offer real-world clinical services based on electronic health records from a UK network of research-active general practices.
- Longitudinal representative data for research – Research-ready anonymised data collated from more than 20 million patients’ electronic health records. With over 30 years’ experience, CPRD’s in-house research team of epidemiologists and statisticians offers advice and support to advance customers’ public health research
- Bespoke data collection – CPRD can assist with the collection of study-specific data to supplement electronic health record data including electronic patient reported outcomes and physician questionnaires
- Recruitment services – CPRD can conduct patient eligibility searches and manage the informed consent process for clinical studies in primary and secondary care settings.
- Trial management services - CPRD offers full management of post-marketing real-world clinical effectiveness studies and pragmatic trials in primary care.
Dr David Mark WrightHead of Clinical Trials
Dr Róisín NicAmhlaoibhHead of Business Development
National Institute for Health Research
The NIHR Clinical Research Network provides free support and guidance to all life sciences industry companies considering running research in the UK.
We offer a free of charge, robust feasibility service to all companies that have eligible study proposals. This includes an expert protocol/synopsis review, providing national level feasibility of the "doability" and compatibility of the trial in the NHS. Along with 2 site level feasibility services, 1 of which identifies potential centers to run your trial, all done within 3 weeks
We have worked with and provided support to over 1000 different companies over the years and we are looking forward to meeting new ones at Bio-Europe Spring to whom we can support.
Mr Theo ChristieBusiness Development Manager
Ms Natalie WilsonBusiness Development Analyst
Scottish Development International
Scottish Development International offers free and confidential support to foreign companies who would like to identify commercial, clinical or academic partners in Scotland. SDI can also offer a wide range of investor support services for companies expanding in Europe.
The Scottish Life Sciences sector consists of over 650 organisations employing over 32,500 people with particular strengths in cell and gene therapy, pharmaceutical services, digital health and clinical translational medicine.
Scotland has a strong cluster of expert, innovative and ambitious companies delivering outsourcing solutions for biopharmaceutical companies globally. This includes both multi-national and niche CROs, innovative drug delivery and formulation specialists and manufacturing services that span drug development.